Poukalov Konstantin
Transactions
26
Companies
8
Filings
10
CIK
0001678736
Recent Transactions
- Award
- Exercise/Conversion
- Exercise/Conversion
- Tax Payment
- Award
- Award
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
- Conversion
- Conversion
- Purchase
- Conversion
- Purchase
- Purchase
- Purchase
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
- Purchase
Companies
8ARYA Sciences Acquisition Corp IV
Chief Business Officer
ARYA Sciences Acquisition Corp V
Chief Business Officer
Cerevel Therapeutics Holdings, Inc.
Chief Business Officer
Kadmon Holdings, Inc.
EVP, Chief Financial Officer
Landos Biopharma, Inc.
Director, 10% Owner
- $LIANY
LianBio
Director
- $LYRA
Lyra Therapeutics, Inc.
Director
- $NAUT
Nautilus Biotechnology, Inc.
Chief Business Officer
Recent Filings
10- 4
Poukalov Konstantin
Jun 14, 2024
- 4
Poukalov Konstantin
Feb 20, 2024
- 4
Poukalov Konstantin
Jul 5, 2023
- 4
Poukalov Konstantin
Jun 23, 2023
- 4
Poukalov Konstantin
Jun 27, 2022
- 4
Poukalov Konstantin
Jun 21, 2022
- 4
Poukalov Konstantin
May 28, 2021
- 4
Poukalov Konstantin
Feb 9, 2021
- 4
Poukalov Konstantin
Feb 8, 2021
- 4
Poukalov Konstantin
May 1, 2020
Address
C/O KADMON HOLDINGS, INC. 450 E 29TH STREET
NEW YORK, NY, 10016